A broader ‘One Health’ and multi-stakeholder approach is urgently needed to address drug-resistant infections. Antimicrobial resistance (AMR) is already a leading cause of death globally, surpassing HIV/AIDS and malaria.
How can novel financing approaches accelerate effective action to address AMR challenges?

Professor of Infectious Diseases, Imperial College London

Chair, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria

Centre for Health and Healthcare, World Economic Forum
The GFC provides strategic and thought leadership to the UCARE initiative aiming to unlock sustainable and synergistic financing from both public and private sources to reduce global deaths associated with AMR, saving more than 100 million lives by 2050.
The network convenes over 700 experts from academia, business, government, civil society and international organizations, operating as a time-bound think-tank, grouped in expertise-based thematic councils, to identify and disseminate transformative ideas with the potential for positive global impact.
Global Future Council on Antimicrobial Resistance
A World Economic Forum Initiative